Asthma: all 4,012 studies

Page 11 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.

• Effects of Whole Sprouts on Airway Allergic InflammationCompletedNCT01522703Not applicableResults posted
• Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term GrowthCompletedNCT01520688Phase 4Results posted
• Reducing Asthma Morbidity In High Risk Minority Preschool ChildrenCompletedNCT01519453Not applicableResults posted
• Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory SymptomsCompletedNCT01518322Results posted
• Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma ExacerbationCompletedNCT01515995Phase 4Results posted
• A Pilot and Feasibility Study of Mobile-Based Asthma Action PlansCompletedNCT01514760Not applicableResults posted
• Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring SystemCompletedNCT01509183Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaCompletedNCT01508936Phase 3Results posted
• A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)CompletedNCT01502371Phase 2Results posted
• Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic ChildrenCompletedNCT01500525Results posted
• Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.CompletedNCT01498679Phase 3Results posted
• Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian AncestryCompletedNCT01498653Phase 3Results posted
• Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT01494610Phase 1/2Results posted
• Role of microRNAs in T Cell-Driven Inflammation in AsthmaCompletedNCT01484691Not applicableResults posted
• A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 DeviceCompletedNCT01484197Phase 2Results posted
• A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsCompletedNCT01479621Phase 2Results posted
• A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe AsthmaCompletedNCT01479595Phase 2Results posted
• Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled AsthmaTerminatedNCT01478360Phase 2Results posted
• SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.CompletedNCT01475721Phase 4Results posted
• Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of AsthmaCompletedNCT01472757Phase 2/3Results posted
• A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)CompletedNCT01471340Phase 4Results posted
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years OldCompletedNCT01462344Phase 4Results posted
• Teaching Use of Respiratory Inhalers (TURI)CompletedNCT01456494Not applicableResults posted
• Impact of Adherence to Treatment in Asthma ControlCompletedNCT01455545Results posted
• Effect of High Dose Ciclesonide on Asthma ControlCompletedNCT01455194Phase 3Results posted
• Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric SubjectsCompletedNCT01453296Phase 2Results posted
• Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD StudyCompletedNCT01453023Phase 2Results posted
• A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and AdolescentsCompletedNCT01444430Phase 3Results posted
• Exercise Training in Asthma ChildrenCompletedNCT01438294Not applicableResults posted
• Long-acting Beta Agonist Step Down StudyCompletedNCT01437995Phase 4Results posted
• Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With AsthmaCompletedNCT01436110Phase 3Results posted
• Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With AsthmaCompletedNCT01436071Phase 3Results posted
• Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and AdolescentsCompletedNCT01431950Phase 3Results posted
• Preventative Omalizumab or Step-up Therapy for Severe Fall ExacerbationsCompletedNCT01430403Phase 4Results posted
• Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.CompletedNCT01425801Phase 2Results posted
• A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent AsthmaCompletedNCT01424813Phase 3Results posted
• Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic AsthmaCompletedNCT01405963Phase 1Results posted
• A Safety and Efficacy Study of Tralokinumab in Adults With AsthmaCompletedNCT01402986Phase 2Results posted
• Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.CompletedNCT01400906Phase 2Results posted
• Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)TerminatedNCT01397201Phase 2Results posted
• Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) TherapyTerminatedNCT01397162Phase 2Results posted
• Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).TerminatedNCT01396278Phase 2Results posted
• Characterization of the Role of Histamine in Children With AsthmaCompletedNCT01392859Phase 2/3Results posted
• Noninvasive Neurostimulation of the Vagus Nerve for the Relief of Acute Bronchoconstriction Due to AsthmaTerminatedNCT01385306Not applicableResults posted
• A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate AsthmaCompletedNCT01383499Phase 2Results posted
• Biomarkers of Cockroach Sublingual Immunotherapy 2CompletedNCT01380327Phase 1/2Results posted
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate AsthmaCompletedNCT01370317Phase 1Results posted
• Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated EosinophilsCompletedNCT01366521Phase 2Results posted
• Bronchial Thermoplasty in Severe Persistent AsthmaCompletedNCT01350336Not applicableResults posted
• Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With AsthmaCompletedNCT01348139Phase 2Results posted
• Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination TherapyCompletedNCT01347060Results posted
• Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma PatientsCompletedNCT01346852Results posted
• A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)CompletedNCT01343407Phase 1Results posted
• Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent AsthmaCompletedNCT01340209Phase 3Results posted
• Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic PatientsCompletedNCT01332292Phase 2Results posted
• The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic AsthmaticsCompletedNCT01329939Not applicableResults posted
• Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care PopulationCompletedNCT01328964Results posted
• Antidepressant Treatment at an Inner City Asthma ClinicCompletedNCT01324700Phase 4Results posted
• Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent AsthmaCompletedNCT01316380Phase 3Results posted
• Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild AsthmaCompletedNCT01316315Phase 1/2Results posted
• Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaCompletedNCT01312961Phase 2Results posted
• Using Computers to Assist in the Treatment of Asthma in a Pediatric SettingCompletedNCT01312805Not applicableResults posted
• A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe AsthmaCompletedNCT01311661Phase 2Results posted
• Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaTerminatedNCT01290887Phase 3Results posted
• Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)CompletedNCT01290874Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01287039Phase 3Results posted
• Nasal Allergen Challenge in Rhinitic SubjectsCompletedNCT01286129Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic AsthmaCompletedNCT01285323Phase 3Results posted
• Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent AsthmaCompletedNCT01277523Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01270464Phase 3Results posted
• A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)CompletedNCT01258803Phase 2Results posted
• Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent AsthmaCompletedNCT01257230Phase 3Results posted
• Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µgCompletedNCT01256086Phase 2Results posted
• Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in AsthmaCompletedNCT01248065Phase 3Results posted
• A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With AsthmaCompletedNCT01244984Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled AsthmaCompletedNCT01238861Phase 2Results posted
• Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.CompletedNCT01233284Phase 2Results posted
• Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the AirwayCompletedNCT01231230Not applicableResults posted
• The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled AllergenCompletedNCT01225549Phase 2Results posted
• Development of Cockroach Immunotherapy by the Inner-City Asthma ConsortiumCompletedNCT01221285Phase 1Results posted
• Acute Airway Vascular Smooth Muscle Effects of Inhaled BudesonideCompletedNCT01219738Not applicableResults posted
• Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma ExacerbationsCompletedNCT01218399Not applicableResults posted
• A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed DosingTerminatedNCT01218009Phase 3Results posted
• Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe AsthmaCompletedNCT01210170Not applicableResults posted
• Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 TherapyCompletedNCT01202903Phase 3Results posted
• A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled AsthmaCompletedNCT01199289Phase 2Results posted
• Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic PatientsCompletedNCT01197794Phase 2Results posted
• Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot StudyCompletedNCT01196377Not applicableResults posted
• A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175)CompletedNCT01193049Phase 1Results posted
• Fall Epidemic Viral Pediatric StudyCompletedNCT01192178Phase 4Results posted
• Dietary Interventions in Asthma Treatment: Sprouts StudyTerminatedNCT01183923Not applicableResults posted
• Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent AsthmaCompletedNCT01181895Phase 3Results posted
• School-Based Preventive Asthma Care Technology: A Trial Using a Novel Technology to Improve AdherenceCompletedNCT01175434Not applicableResults posted
• School-based Asthma Therapy: Stage 2 Effectiveness StudyCompletedNCT01175369Not applicableResults posted
• A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionCompletedNCT01175226Phase 2Results posted
• Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma IICompletedNCT01172821Phase 3Results posted
• Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma ICompletedNCT01172808Phase 3Results posted
• A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in AsthmaCompletedNCT01167010Phase 3Results posted
• Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsCompletedNCT01165138Phase 3Results posted
• Teen Asthma ProjectCompletedNCT01161225Not applicableResults posted

← Asthma overview